Basic Lab Markers
|
August 30, 2024

Understanding High AST Levels: Causes and Implications

Medically Reviewed by
Updated On
September 22, 2024

Aspartate aminotransferase (AST) is an enzyme concentrated in the liver. It becomes elevated in response to tissue damage or disease, making it a valuable biomarker for liver health. According to the Centers for Disease Control and Prevention, liver disease affects approximately 4.5 million adults in the United States, highlighting the importance of AST in early detection and intervention. 

However, AST is also found in other tissues, and elevated AST levels can signal a range of issues, from heart disease to muscle disorders. Understanding the causes, implications, and diagnostic processes associated with high AST levels makes health and diagnostic evaluations more efficient. 

[signup]

What Is AST?

Aspartate aminotransferase (AST) is an enzyme found primarily in the liver, heart, and skeletal muscles, but it is also present in smaller amounts in other tissues and organs, such as the pancreas and kidneys. It helps process proteins by moving a part of aspartate, an amino acid, to alpha-ketoglutarate, creating oxaloacetate and glutamate. Oxaloacetate enters the Krebs cycle – also known as the citric acid or TCA cycle – a series of reactions that produce energy (called ATP) for our cells. (4

AST is significant because elevated levels in the blood can indicate tissue damage or disease. Under normal conditions, AST levels in the blood are low. However, when cells in organs where AST is abundant are damaged, AST is released into the bloodstream, causing elevated levels. This is why AST is often measured in blood tests as a marker for liver health. (4, 17

Sign up for free to order AST lab tests!

Normal Results

Reference ranges for AST are listed below. Normal values may vary slightly between different laboratories. Age and gender will influence normal ranges. 

Children:

  • 0-5 days: 35-140 U/L
  • < 3 years: 15-60 U/L
  • 3-6 years: 15-50 U/L
  • 6-12 years: 10-50 U/L
  • 12-18 years: 10-40 U/L

Adults: 0-35 U/L (values tend to be slightly lower in females than males)

Elderly: Values are slightly higher than those of other adults

Order AST Through: 

Sign up for free to order AST lab tests!

Causes of High AST Levels

AST is a non-specific marker, meaning that elevated levels in the blood can indicate damage or disease in a variety of tissues, not just a single organ. Since AST is present in the liver, heart, muscles, kidneys, and brain, an increase in its levels could result from conditions affecting any of these tissues. 

Liver Conditions

Hepatitis is a medical condition characterized by inflammation of the liver, which can impair its function and lead to various health complications. It can be caused by viral infections (hepatitis viruses A, B, C, D, and E), metabolic disorders, excessive alcohol consumption, exposure to certain medications and toxins, and autoimmune disease.

Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of excess fat in the liver cells of people who consume little to no alcohol. It is a spectrum of liver diseases that ranges from simple steatosis (fat accumulation without significant inflammation or liver damage) to non-alcoholic steatohepatitis (NASH), which includes inflammation and can progress to fibrosis, cirrhosis, and liver failure. NAFLD is commonly associated with metabolic syndrome, obesity, insulin resistance, type 2 diabetes, and dyslipidemia. (42

Cirrhosis is a late-stage chronic liver disease characterized by scarring (fibrosis) of liver tissue, leading to impaired liver structure and function. 

Liver cancer originates in the liver cells and is most commonly classified as hepatocellular carcinoma (HCC). Other types, such as cholangiocarcinoma and hepatoblastoma, are less common. Risk factors for liver cancer include chronic viral hepatitis, cirrhosis, NAFLD, aflatoxin (a toxic substance produced by certain molds) exposure, and excessive alcohol consumption.

Heart Conditions

Myocardial infarction (MI), more commonly known as a heart attack, occurs when blood flow to a part of the heart muscle is blocked for an extended period, leading to damage or death of the heart tissue. This blockage is typically caused by the buildup of plaque in the coronary arteries, resulting in the rupture of the plaque and the formation of a blood clot. In an acute MI, AST will begin to elevate 6-8 hours after symptom onset, reach peak levels at 24-36 hours, and return to baseline in 3-7 days.

Elevated AST can be measured in other forms of heart disease, including congestive heart failure (CHF) and myocarditis.

Muscle Disorders

Muscle injury or trauma can result in either transient elevations of AST in cases of acute injury or sustained elevations in chronic injury or inflammation. Examples include:

  • Exercise
  • Rhabdomyolysis (a serious condition where damaged muscles release proteins and electrolytes into the bloodstream)
  • Muscular dystrophy (a group of genetic disorders causing progressive muscle weakness and loss of muscle mass)
  • Polymyositis (a rare inflammatory disease that causes muscle weakness and inflammation)

Other Causes

Other causes of elevated AST levels include: 

  • Pancreatitis
  • Hemochromatosis 
  • Mononucleosis
  • Seizure
  • Hemolysis (destruction of red blood cells) 
  • Surgery
  • Pregnancy
  • Medications, including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors, nicotinic acid, isoniazid, sulfonamides, erythromycin, and antifungals  

Symptoms and Health Implications

Symptoms experienced by patients with elevated AST can vary depending on the underlying cause. 

In cases related to liver disease, symptoms may include: 

  • Jaundice (a yellowing of the skin and eyes)
  • Fatigue
  • Abdominal pain
  • Ascites (abdominal fluid accumulation)
  • Itching
  • Light colored stools
  • Dark urine
  • Weight loss

When liver disease goes untreated, it can progress to end-stage liver disease and liver failure. Complications of portal hypertension and liver cancer are the leading causes of hospitalization and death in people with liver failure. (32

Cardiovascular disease, which encompasses coronary artery disease (CAD), peripheral artery disease (PAD), heart attack, heart failure, and stroke, is responsible for one in five deaths in the United States, making it the leading cause of death. Patients with cardiovascular conditions that manifest with elevated AST levels may report:

  • Chest pain
  • Shortness of breath
  • Claudication (pain in the arms or legs that occurs with walking) 
  • Edema
  • Dizziness
  • Irregular heartbeat 

Muscle weakness and pain are the most common symptoms of myopathies. Untreated muscle disorders will lead to progressive muscle weakness and reduced mobility.

Diagnosis and Evaluation

AST's nonspecificity necessitates the use of additional tests and clinical information to accurately diagnose the underlying cause of elevated AST levels. 

Medical History and Physical Examination

Patient evaluation should begin with gathering a detailed patient history and conducting a thorough physical examination to identify potential causes of elevated AST. 

Doctors should ask patients about: 

  • Recent trauma
  • Alcohol use
  • Risk factors for viral hepatitis, including IV drug use, exposure to non-sterile needles, and blood transfusions
  • Supplements and medications 
  • Diet and exercise 
  • Symptoms of liver, heart, and muscle disease

A comprehensive physical exam should include the following components:

  • Vitals
  • Cardiovascular
  • Pulmonary
  • Abdominal
  • Skin

Other Lab Tests and Biomarkers

Obtain a complete hepatic function panel, including: 

  • Alanine aminotransferase (ALT)
  • Alkaline phosphatase (ALP)
  • Gamma-glutamyl transferase (GGT)
  • Bilirubin 
  • Lactate dehydrogenase (LDH)

Liver disease often manifests with abnormal findings of multiple liver biomarkers. Specific patterns can help narrow the differential diagnosis. For example: 

  • Acute viral hepatitis or acetaminophen toxicity are likely when aminotransferase levels are greater than 500 U/L.
  • An AST:ALT ratio greater than 2 is indicative of alcoholic liver disease.
  • AST and ALT are typically 7-10 times the upper limit of normal in autoimmune hepatitis.

A serum AST:ALT ratio greater than 5 indicates extrahepatic injury, especially if ALT is normal. Additional tests to investigate for extrahepatic causes of elevated AST include: 

Imaging Studies

Liver enzymes will normalize after 2-4 weeks in about one-third of people with elevated liver enzymes. If your enzymes stay high, your doctor will likely order imaging tests, such as ultrasound, CT scan, or MRI, to evaluate further. Sometimes, a liver biopsy is also indicated for diagnosing liver conditions.

Treatment and Management

The course of treatment for elevated AST is dependent on the underlying cause. Examples may include: 

  • Eating an anti-inflammatory diet and exercising at least 150 minutes weekly to support liver and heart health. 
  • Discontinue alcohol and hepatotoxic medication use
  • Lose weight (if overweight)
  • Treat diabetes, high blood pressure, and high cholesterol (if conditions are present)
  • Take liver-supporting supplements, such as milk thistle, turmeric, and dandelion root, to counteract liver damage and combat oxidative stress.
  • Take supplements that support the cardiovascular system, such as hawthorn berry, garlic, omega-3 fatty acids, and magnesium.
  • In some cases, doctors will prescribe medications to manage underlying health conditions. These should be taken as prescribed. 

Guidelines typically recommend remeasuring liver enzymes in 1 to 3-month increments to monitor. Additional tests or imaging should be ordered, as necessary, if AST levels do not normalize. 

[signup]

Key Takeaways

  • Aspartate aminotransferase (AST) is an enzyme commonly used as a biomarker for liver health, but elevated levels in blood tests can indicate various underlying health conditions, including liver disease, heart conditions, and muscle disorders. 
  • Diagnosis involves a comprehensive approach, utilizing medical history, physical examination, additional tests, and imaging studies to identify the specific cause. 
  • Treatment strategies depend on the underlying condition, and they can range from lifestyle modifications to medications. Early intervention and regular follow-ups can prevent progression to more serious health complications and improve long-term outcomes. 

Aspartate aminotransferase (AST) is an enzyme concentrated in the liver. It may become elevated in response to tissue damage or disease, making it a useful indicator for liver health. According to the Centers for Disease Control and Prevention, liver disease affects approximately 4.5 million adults in the United States, highlighting the importance of AST in monitoring liver function. 

However, AST is also found in other tissues, and elevated AST levels can signal a range of issues, from heart conditions to muscle disorders. Understanding the causes, implications, and diagnostic processes associated with high AST levels can help in health evaluations. 

[signup]

What Is AST?

Aspartate aminotransferase (AST) is an enzyme found primarily in the liver, heart, and skeletal muscles, but it is also present in smaller amounts in other tissues and organs, such as the pancreas and kidneys. It helps process proteins by moving a part of aspartate, an amino acid, to alpha-ketoglutarate, creating oxaloacetate and glutamate. Oxaloacetate enters the Krebs cycle – also known as the citric acid or TCA cycle – a series of reactions that produce energy (called ATP) for our cells. (4

AST is significant because elevated levels in the blood can suggest tissue damage or disease. Under normal conditions, AST levels in the blood are low. However, when cells in organs where AST is abundant are damaged, AST is released into the bloodstream, causing elevated levels. This is why AST is often measured in blood tests as a marker for liver health. (4, 17

Normal Results

Reference ranges for AST are listed below. Normal values may vary slightly between different laboratories. Age and gender will influence normal ranges. 

Children:

  • 0-5 days: 35-140 U/L
  • < 3 years: 15-60 U/L
  • 3-6 years: 15-50 U/L
  • 6-12 years: 10-50 U/L
  • 12-18 years: 10-40 U/L

Adults: 0-35 U/L (values tend to be slightly lower in females than males)

Elderly: Values are slightly higher than those of other adults

Order AST Through: 

Causes of High AST Levels

AST is a non-specific marker, meaning that elevated levels in the blood can indicate damage or disease in a variety of tissues, not just a single organ. Since AST is present in the liver, heart, muscles, kidneys, and brain, an increase in its levels could result from conditions affecting any of these tissues. 

Liver Conditions

Hepatitis is a medical condition characterized by inflammation of the liver, which can impair its function and lead to various health complications. It can be caused by viral infections (hepatitis viruses A, B, C, D, and E), metabolic disorders, excessive alcohol consumption, exposure to certain medications and toxins, and autoimmune disease.

Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of excess fat in the liver cells of people who consume little to no alcohol. It is a spectrum of liver diseases that ranges from simple steatosis (fat accumulation without significant inflammation or liver damage) to non-alcoholic steatohepatitis (NASH), which includes inflammation and can progress to fibrosis, cirrhosis, and liver failure. NAFLD is commonly associated with metabolic syndrome, obesity, insulin resistance, type 2 diabetes, and dyslipidemia. (42

Cirrhosis is a late-stage chronic liver disease characterized by scarring (fibrosis) of liver tissue, leading to impaired liver structure and function. 

Liver cancer originates in the liver cells and is most commonly classified as hepatocellular carcinoma (HCC). Other types, such as cholangiocarcinoma and hepatoblastoma, are less common. Risk factors for liver cancer include chronic viral hepatitis, cirrhosis, NAFLD, aflatoxin (a toxic substance produced by certain molds) exposure, and excessive alcohol consumption.

Heart Conditions

Myocardial infarction (MI), more commonly known as a heart attack, occurs when blood flow to a part of the heart muscle is blocked for an extended period, leading to damage or death of the heart tissue. This blockage is typically caused by the buildup of plaque in the coronary arteries, resulting in the rupture of the plaque and the formation of a blood clot. In an acute MI, AST will begin to elevate 6-8 hours after symptom onset, reach peak levels at 24-36 hours, and return to baseline in 3-7 days.

Elevated AST can be measured in other forms of heart disease, including congestive heart failure (CHF) and myocarditis.

Muscle Disorders

Muscle injury or trauma can result in either transient elevations of AST in cases of acute injury or sustained elevations in chronic injury or inflammation. Examples include:

  • Exercise
  • Rhabdomyolysis (a serious condition where damaged muscles release proteins and electrolytes into the bloodstream)
  • Muscular dystrophy (a group of genetic disorders causing progressive muscle weakness and loss of muscle mass)
  • Polymyositis (a rare inflammatory disease that causes muscle weakness and inflammation)

Other Causes

Other causes of elevated AST levels include: 

  • Pancreatitis
  • Hemochromatosis 
  • Mononucleosis
  • Seizure
  • Hemolysis (destruction of red blood cells) 
  • Surgery
  • Pregnancy
  • Medications, including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), ACE inhibitors, nicotinic acid, isoniazid, sulfonamides, erythromycin, and antifungals  

Symptoms and Health Implications

Symptoms experienced by patients with elevated AST can vary depending on the underlying cause. 

In cases related to liver disease, symptoms may include: 

  • Jaundice (a yellowing of the skin and eyes)
  • Fatigue
  • Abdominal pain
  • Ascites (abdominal fluid accumulation)
  • Itching
  • Light colored stools
  • Dark urine
  • Weight loss

When liver disease is not managed, it can progress to end-stage liver disease and liver failure. Complications of portal hypertension and liver cancer are significant concerns in people with liver failure. (32

Cardiovascular disease, which encompasses coronary artery disease (CAD), peripheral artery disease (PAD), heart attack, heart failure, and stroke, is responsible for one in five deaths in the United States, making it the leading cause of death. Patients with cardiovascular conditions that manifest with elevated AST levels may report:

  • Chest pain
  • Shortness of breath
  • Claudication (pain in the arms or legs that occurs with walking) 
  • Edema
  • Dizziness
  • Irregular heartbeat 

Muscle weakness and pain are the most common symptoms of myopathies. If not addressed, muscle disorders may lead to progressive muscle weakness and reduced mobility.

Diagnosis and Evaluation

AST's nonspecificity necessitates the use of additional tests and clinical information to accurately identify the underlying cause of elevated AST levels. 

Medical History and Physical Examination

Patient evaluation should begin with gathering a detailed patient history and conducting a thorough physical examination to identify potential causes of elevated AST. 

Doctors should ask patients about: 

  • Recent trauma
  • Alcohol use
  • Risk factors for viral hepatitis, including IV drug use, exposure to non-sterile needles, and blood transfusions
  • Supplements and medications 
  • Diet and exercise 
  • Symptoms of liver, heart, and muscle disease

A comprehensive physical exam should include the following components:

  • Vitals
  • Cardiovascular
  • Pulmonary
  • Abdominal
  • Skin

Other Lab Tests and Biomarkers

Obtain a complete hepatic function panel, including: 

  • Alanine aminotransferase (ALT)
  • Alkaline phosphatase (ALP)
  • Gamma-glutamyl transferase (GGT)
  • Bilirubin 
  • Lactate dehydrogenase (LDH)

Liver disease often manifests with abnormal findings of multiple liver biomarkers. Specific patterns can help narrow the differential diagnosis. For example: 

  • Acute viral hepatitis or acetaminophen toxicity are likely when aminotransferase levels are greater than 500 U/L.
  • An AST:ALT ratio greater than 2 is indicative of alcoholic liver disease.
  • AST and ALT are typically 7-10 times the upper limit of normal in autoimmune hepatitis.

A serum AST:ALT ratio greater than 5 indicates extrahepatic injury, especially if ALT is normal. Additional tests to investigate for extrahepatic causes of elevated AST include: 

Imaging Studies

Liver enzymes will normalize after 2-4 weeks in about one-third of people with elevated liver enzymes. If your enzymes stay high, your doctor will likely order imaging tests, such as ultrasound, CT scan, or MRI, to evaluate further. Sometimes, a liver biopsy is also indicated for diagnosing liver conditions.

Treatment and Management

The course of treatment for elevated AST is dependent on the underlying cause. Examples may include: 

  • Considering an anti-inflammatory diet and exercising at least 150 minutes weekly to support liver and heart health. 
  • Avoiding alcohol and hepatotoxic medication use
  • Managing weight (if overweight)
  • Addressing diabetes, high blood pressure, and high cholesterol (if conditions are present)
  • Considering liver-supporting supplements, such as milk thistle, turmeric, and dandelion root, which may help support liver health.
  • Considering supplements that support the cardiovascular system, such as hawthorn berry, garlic, omega-3 fatty acids, and magnesium.
  • In some cases, doctors will prescribe medications to manage underlying health conditions. These should be taken as prescribed. 

Guidelines typically recommend remeasuring liver enzymes in 1 to 3-month increments to monitor. Additional tests or imaging should be ordered, as necessary, if AST levels do not normalize. 

[signup]

Key Takeaways

  • Aspartate aminotransferase (AST) is an enzyme commonly used as an indicator for liver health, but elevated levels in blood tests can suggest various underlying health conditions, including liver disease, heart conditions, and muscle disorders. 
  • Diagnosis involves a comprehensive approach, utilizing medical history, physical examination, additional tests, and imaging studies to identify the specific cause. 
  • Treatment strategies depend on the underlying condition, and they can range from lifestyle modifications to medications. Early intervention and regular follow-ups can help manage progression to more serious health complications and support long-term outcomes. 
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

  1. Alabduladhem, T. O., & Bordoni, B. (2022, November 23). Physiology, Krebs Cycle. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556032/
  2. Anderson, S. (2022, May 19). 6 Preventable Risk Factors Associated With Heart Attacks. Rupa Health. https://www.rupahealth.com/post/5-things-to-do-after-a-heart-attack
  3. Aspartate Aminotransferase. Rupa Health. https://www.rupahealth.com/biomarkers/ast
  4. Aspartate Aminotransferase. ScienceDirect. https://www.sciencedirect.com/topics/neuroscience/aspartate-aminotransferase
  5. Aspartate aminotransferase (AST) blood test. Mount Sinai Health System. https://www.mountsinai.org/health-library/tests/aspartate-aminotransferase-ast-blood-test
  6. Blake, K. (2023, April 28). What Is a Heart Healthy Diet and Who Should Follow One? Rupa Health. https://www.rupahealth.com/post/what-is-a-heart-healthy-diet-and-who-should-follow-one
  7. Botros, M., & Sikaris, K. A. (2013). The de ritis ratio: the test of time. The Clinical Biochemist. Reviews, 34(3), 117–130. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866949/
  8. Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesity
  9. Chronic Liver Disease and Cirrhosis. (2019, October 11). Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/fastats/liver-disease.htm
  10. Cloyd, J. (2023, May 1). A Functional Medicine Protocol for Coronary Artery Disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-coronary-artery-disease
  11. Cloyd, J. (2023, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/the-role-of-nutrition-and-dietary-supplements-in-preventing-and-managing-cardiovascular-disease
  12. Cloyd, J. (2023, June 19). A Functional Medicine Post Stroke Protocol: Testing, Therapeutic Diet, and Integrative Therapy Options. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-post-stroke-protocol-testing-supplements-and-integrative-therapy-options
  13. Cloyd, J. (2023, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health. https://www.rupahealth.com/post/the-role-of-physical-activity-and-exercise-in-promoting-heart-health-including-the-use-of-alternative-exercise-modalities-such-as-tai-chi-and-qigong
  14. Cloyd, J. (2023, August 21). Thyroid Hormone Testing Guide: A Comprehensive Review of How to Test for Thyroid Hormones. Rupa Health. https://www.rupahealth.com/post/thyroid-hormone-testing-guide-a-comprehensive-review-of-how-to-test-for-thyroid-hormones
  15. Cloyd, J. (2023, September 8). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Hepatitis. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-hepatitis
  16. Cloyd, J. (2023, November 1). How To Interpret Your Celiac Blood Test Results. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-celiac-blood-test-results
  17. Cloyd, J. (2024, January 22). Interpreting Liver Enzyme Tests: ALT, AST, and ALP in Liver Health Monitoring. Rupa Health. https://www.rupahealth.com/post/interpreting-liver-enzyme-tests-alt-ast-and-alp-in-liver-health-monitoring
  18. Cloyd, J. (2024, January 26). Cardiac Risk Assessment: When to Utilize Troponin and NT-proBNP Tests. Rupa Health. https://www.rupahealth.com/post/cardiac-risk-assessment-when-to-utilize-troponin-and-nt-probnp-tests
  19. Cloyd, K. (2023, December 19). How to interpret your lipid panel results. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-lipid-panel-results
  20. Cobbold, J. F., Anstee, Q. M., & Thomas, H. C. (2010). Raised serum aminotransferases and muscle disease. BMJ. https://doi.org/10.1136/bmj.c4039
  21. Common Tests for Liver Disease. Cleveland Clinic. https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/liver-tests#determination-of-specific-liver-disorders-tab
  22. Creatine Kinase. Rupa Health. https://www.rupahealth.com/biomarkers/creatine-kinase
  23. DePorto, T. (2022, December 9). Functional Medicine Lab Tests for Heart Disease. Rupa Health. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointment
  24. Elevated Liver Enzymes. (2018). Cleveland Clinic. https://my.clevelandclinic.org/health/symptoms/17679-elevated-liver-enzymes
  25. Ewid, M., Sherif, H., Allihimy, A. S., et al. (2020). AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction. BMC Research Notes, 13. https://doi.org/10.1186/s13104-020-05031-3
  26. Greenan, S. (2021, October 11). 7 Early Signs Of Insulin Resistance. Rupa Health. https://www.rupahealth.com/post/what-is-insulin-resistance
  27. Hepatic Testing. (n.d.). Rupa Health. https://www.rupahealth.com/health-categories/hepatic
  28. Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs
  29. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology, 112(1), 18–35. https://doi.org/10.1038/ajg.2016.517
  30. Liver biopsy. (2018). Mayo Clinic. https://www.mayoclinic.org/tests-procedures/liver-biopsy/about/pac-20394576
  31. Liver cancer. (2023, April 28). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/liver-cancer/symptoms-causes/syc-20353659
  32. Liver Disease. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17179-liver-disease#symptoms-and-causes
  33. Louisiana Office of Public Health Laboratories. (2013). https://ldh.la.gov/assets/oph/Center-PHCH/Center-CH/lab/CTAgents/ClinicalChemistry03052016.pdf
  34. Maholy, N. (2023, March 9). Integrative Medicine Protocol For Reversing Type 2 Diabetes. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-protocol-for-reversing-type-2-diabetes
  35. Maholy, N. (2023, May 23). A Functional Medicine Treatment Protocol for Metabolic Syndrome: Testing, Nutrition, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-treatment-protocol-for-metabolic-syndrome-testing-nutrition-and-supplements
  36. Mehta, N. (2020). Drug-Induced Hepatotoxicity. Medscape. https://emedicine.medscape.com/article/169814-overview#a3
  37. Nagy, H., & Veerapaneni, K. D. (2021). Myopathy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK562290/
  38. Ndrepepa, G. (2021). Aspartate aminotransferase and cardiovascular disease—a narrative review. Journal of Laboratory and Precision Medicine, 6(0). https://doi.org/10.21037/jlpm-20-93
  39. Robinson, K. (2024, June 28). Living Well with Hemochromatosis: Understanding and Managing Iron Overload. Rupa Health. https://www.rupahealth.com/post/living-well-with-hemochromatosis-understanding-and-managing-iron-overload
  40. Sweetnich, J. (2023, May 19). Overview of The Liver 101: Top Conditions, Specialty Testing, and Integrative Medicine Treatment Options. Rupa Health. https://www.rupahealth.com/post/overview-liver-101-top-conditions-and-testing
  41. Vasbinder, A., Chen, Y., Procureur, A., et al. (2022). Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis. JACC. CardioOncology, 4(5), 689–700. https://doi.org/10.1016/j.jaccao.2022.11.004
  42. Weinberg, J. L. (2022, May 3). Tiredness, weight loss, and itching are signs of this dangerous liver disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-non-alcoholic-fatty-liver-disease
  43. Weinberg, J. L. (2022, October 4). Pancreatitis: Causes, Risk Factors, and Treatments. Rupa Health. https://www.rupahealth.com/post/pancreatitis-causes-risk-factors-and-treatments
  44. Weinberg, J. L. (2023, September 15). An Integrative Medicine Approach to Autoimmune Hepatitis. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-autoimmune-hepatitis
  45. Williams, A. L. B., & Hoofnagle, J. H. (1988). Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis. Gastroenterology, 95(3), 734–739. https://doi.org/10.1016/s0016-5085(88)80022-2
  46. Woreta, T. A., & Alqahtani, S. A. (2014). Evaluation of Abnormal Liver Tests. Medical Clinics of North America, 98(1), 1–16. https://doi.org/10.1016/j.mcna.2013.09.005
  47. Yoshimura, H. (2023, March 30). The Importance of Running Comprehensive Metabolic Panel (CMP) on Your Patients. Rupa Health. https://www.rupahealth.com/post/the-importance-of-running-comprehensive-metabolic-panel-cmp-on-your-patients
  48. Yoshimura, H. (2023, October 12). An Integrative and Complementary Approach to Hepatitis C. Rupa Health. https://www.rupahealth.com/post/an-integrative-and-complementary-approach-to-hepatitis-c
  49. Yoshimura, H. (2023, October 16). An Integrative Approach to Liver Cirrhosis Management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-liver-cirrhosis-management
  50. Yoshimura, H. (2023, October 19). What is alcohol-related liver disease and how can functional medicine help? Rupa Health. https://www.rupahealth.com/post/what-is-alcohol-related-liver-disease-and-how-can-functional-medicine-help
  51. Yoshimura, H. (2023, October 23). How to Support Your Liver Health With Nutritional Interventions in Functional Medicine. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-functional-medicine-for-liver-support
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Basic Lab Markers
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.